Senior insider sale
CHIEF MEDICAL OFFICER at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$209.3K
14.56K shares
What this filing means
ZOJWALLA NASEEM plans to sell 14.56K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $209.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/22/2023ACC: 0001959173-23-004942
Officer· CHIEF MEDICAL OFFICER
Since Jan 2022
14.56K
Shares to sell
$209.3K
Approx. market value
7.09K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
11/21/2023
7.09KTotal acquired7.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/21/2023 | Restricted Stock Vesting Compensation | 7.09K | — |
| Total | 7.09K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.46K
Market value
$110.7K
11/21/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.09K
Market value
$98.6K
11/22/2023
Total
Units
14.56K
Value
$209.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/21/2023 | 7.46K | $110.7K | — | Completed |
| Planned — Approximate Date | ||||
11/22/2023 | 7.09K | $98.6K | NASDAQ | Planned |
| Total | 14.56K | $209.3K | ||